Skip to main content

The use of prostaglandin E1 for diagnosis and treatment of erectile dysfunction

World Journal of Urology volume 8, pages 84–86 (1990)Cite this article

Summary

Since 1982, many substances have been used for intracavernous injection to produce erections. Because the first-generation drugs (phenoxybenzamine, papaverine) were associated with severe side effects, including priapism and fibrosis of the penis, it was important that a safe and effective substance for intracavernous injection be found. In our series of 550 men with erectile dysfunction who received a test dose of 20 μg prostaglandin E1, 385 (70%) developed an erection lasting more than 30 min. Side effects were minimal: only one patient required treatment for priapism, and no fibrosis was found. A total of 275 patients entered an autoinjection protocol. All of these men were capable of engaging in intercourse and experienced no major side effects. In conclusion, prostaglandin E1 is effective, safe and preferable to all other drugs currently used for intracavernous injection.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Aboseif SR, Breza J, Bosch RJLH, Benard F, Stief CG, Stackl W, Lue TF, Tanagho EA (1989) Local and systemic effects of chronic intracavernous injection of papaverine, prostaglandin E1 and saline in primates. J Urol 142:403–408

    Google Scholar 

  2. Battez G, Poulet L (1913) Action de l'extrait de prostate humaine sur la vessie et sur la pression artérielle. CR Soc Biol (Paris) 74:8–9

    Google Scholar 

  3. Bergström S, Sjövall J (1957) The isolation of prostaglandin. Acta Chem Scand 11:1086–1092

    Google Scholar 

  4. Bergström S, Ryhage R, Samuelsson B, Sjövall J (1962) The structure of prostaglandin E1, F1 and F2. Acta Chem Scand 16:501–515.

    Google Scholar 

  5. Coceani F, Olley PM, Lock JE (1980) Prostaglandins, ductus arteriosus, pulmonary circulation: current concepts and clinical potential. Eur J Clin Pharmacol 18:75–78

    Google Scholar 

  6. Euler US von (1935) Über die spezifische blutdrucksenkende Substanz des menschlichen Prostata- und Samenblasensekrets. Klin Wochenschr 14:1182–1183

    Google Scholar 

  7. Golub M, Zia P, Matsuno M, Horton R (1975) Metabolism of prostaglandins A1 and E1 in man. J Clin Invest 56:1404–1410

    Google Scholar 

  8. Hedlund H, Andersson KE (1985) Contraction and relaxation induced by some prostanoids in isolated human penile tissue and cavernous artery. J Urol 134:1245–1250

    Google Scholar 

  9. Hwang T, Yang C, Wang S, Chang CL, Tzai T, Chang CH, Wu H (1989) Impotence evaluated by the use of prostaglandin E1. J Urol 141:1357–1359

    Google Scholar 

  10. Jünemann KP, Alken P (1989) Pharmacotherapy of erectile dysfunction: a review. Int J Impotence Res 1:71–93

    Google Scholar 

  11. Kurzrock R, Lieb CC (1930) Biochemical studies of human semen: II. The action of semen on the human uterus. Proc Soc Exp Biol Med 28:268–272

    Google Scholar 

  12. Lee LM, Stevenson RWD, Szasz G (1989) Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. J Urol 141:549–550

    Google Scholar 

  13. Roy AC, Tan SM, Kottegoda SR, Ratnam SS (1984) Ability of human corpora cavernosa muscle to generate prostaglandins and thromboxanes in vitro. IRCS Med Sci 12:608–609

    Google Scholar 

  14. Seidmon EJ, Samaha AM (1989) The pH analysis of papaverine-phentolamine and prostaglandin E1 for pharmacological erection. J Urol 141:1458–1459

    Google Scholar 

  15. Stackl W, Hasun R, Marberger M (1988) Intracavernous injection of prostaglandin E1 in impotent men. J Urol 140:66–68

    Google Scholar 

  16. Stackl W, Loupal G, Holzmann A (1988) Intracavernous injection of vasoactive drugs in the rabbit. Urol Res 16:455–458

    Google Scholar 

  17. Stackl W, Stief CG, Benard F, Aboseif SR, Bosch RJLH, Loupal G, Lue TF, Tanagho EA (1989) Intracavernous injections of solutions with different osmolarity and pH in the rabbit. Int J Impotence Res 1:197–200

    Google Scholar 

  18. Svanborg K, Bygdeman M, Eneroth P, Bendvold E (1982) Quantification of prostaglandins in human seminal fluid. Prostaglandins 24:363–366

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Rudolfstiftung, Juchgasse 25, A-1030, Vienna, Austria

    W. Stackl, R. Hasun & M. Marberger

Authors
  1. W. Stackl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Hasun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Marberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Stackl, W., Hasun, R. & Marberger, M. The use of prostaglandin E1 for diagnosis and treatment of erectile dysfunction. World J Urol 8, 84–86 (1990). https://doi.org/10.1007/BF01576353

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01576353

Keywords

  • Public Health
  • Prostaglandin
  • Erectile Dysfunction
  • Papaverine
  • Severe Side Effect